Prediction of declining renal function and albuminuria in patients with type 2 diabetes by metabolomics

Journal of Clinical Endocrinology and Metabolism

Volumn 101, Issue 2, 2016, Pages 696-704

  Solini, Anna ^a   Manca, Maria Laura ^a,b   Penno, Giuseppe ^a   Pugliese, Giuseppe ^c   Cobb, Jeff E ^d   Ferrannini, Ele ^a,e  

^a Department of Clinical and Experimental Medicine ^*  (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d METABOLON INC   (United States)

^e INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C GLYCOSYL TRYPTOPHAN; CREATININE; GLYCOSYLATED HEMOGLOBIN; N ACETYLTHREONINE; PSEUDOURIDINE; THREONINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; DIABETIC NEPHROPATHY; DISEASE COURSE; KIDNEY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY; MALE; METABOLOMICS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84959421611     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-3345     Document Type: Article

References (35)

1. Pugliese G. Updating the natural history of diabetic nephropathy. Acta Diabetol. 2014;51:905-915.
2. Weil EJ, Lemley KV, Mason CC, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int. 2012;82: 1010-1017.
3. Kato M, Natarajan R. Diabetic nephropathy-emerging epigenetic mechanisms. Nat Rev Nephrol. 2014;10:517-530.
4. Ninomiya T, Perkovic V, de Galan BE, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813-1821.
5. Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011; 29:1802-1809.
6. Klepacki J, Klawitter J, Klawitter J, Thurman JM, Christians U. A high-performance liquid chromatography-tandem mass spectrometry-based targeted metabolomics kidney dysfunction marker panel in human urine. Clin Chim Acta. 2015;446:43-53.
7. Nkuipou-Kenfack E, Duranton F, Gayrard N, et al. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One. 2014;9:e96955.
8. Yu B, Zheng Y, Nettleton JA, Alexander D, Coresh J, Boerwinkle E. Serum metabolomic profiling and incident CKD among African Americans. Clin J Am Soc Nephrol. 2014;9:1410-1417.
9. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
10. Reitman ZJ, Jin G, Karoly ED, et al. Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA. 2011;108:3270-3275.
11. Breiman L. Random forests. Machine Learning. 2001;45:5-32.
12. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-2504.
13. Pena MJ, Lambers Heerspink HJ, Hellemons ME, et al. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with type 2 diabetes mellitus. Diabet Med. 2014; 31:1138-1147.
14. Sharma K, Karl B, Mathew AV, et al. Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol. 2013;24:1901-1912.
15. Hirayama A, Nakashima E, Sugimoto M, et al. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem. 2012;404:3101-3109.
16. Niewczas MA, Sirich TL, Mathew AV, et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 2014;85:1214-1224.
17. Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol. 2011;6:2444-2451.
18. Amin AP, Whaley-Connell AT, Li S, et al. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013;61(4 suppl 2):S12-S23.
19. Dzúrik R, Lajdová I, Spustová V, Opatrný K Jr. Pseudouridine excretion in healthy subjects and its accumulation in renal failure. Nephron. 1992;61:64-67.
20. Morris JH, Apeltsin L, Newman AM, et al. ClusterMaker: a multialgorithm clustering plugin for Cytoscape. BMC Bioinformatics. 2011;12:436.
21. Ueno T, Kobayashi N, Nakayama M, et al. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int. 2013;83:1065-1075.
22. Gagliardini E, Perico N, Rizzo P, et al. Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathway. Am J Pathol. 2013;183:119-130.
23. Sörensen-Zender I, Rong S, Susnik N, et al. Renal tubular Notch signaling triggers a prosenescent state after acute kidney injury. AmJ Physiol Renal Physiol. 2014;306:F907-F915.
24. Takahira R, Yonemura K, Yonekawa O, et al. Tryptophan glycoconjugate as a novel marker of renal function. Am J Med. 2001; 110:192-197.
25. Yonemura K, Takahira R, Yonekawa O, Wada N, Hishida A. The diagnostic value of serum concentrations of 2-(-mannopyranosyl)-L-tryptophan for normal renal function. Kidney Int. 2004;65:1395-1399.
26. Saito K, Fujigaki S, Heyes MP, et al. Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency. Am J Physiol Renal Physiol. 2000;279:F565-F572.
27. Pawlak D, Pawlak K, Malyszko J, Mysliwiec M, Buczko W. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol. 2001;33:399-404.
28. Sallée M, Dou L, Cerini C, Poitevin S, Brunet P, Burtey S. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease. Toxins (Basel). 2014;6: 934-949.
29. Ujcikova H, Eckhardt A, Kagan D, Roubalova L, Svoboda P. Proteomic analysis of post-nuclear supernatant fraction and percollpurified membranes prepared from brain cortex of rats exposed to increasing doses of morphine. Proteome Sci. 2014;12:11.
30. Singh DK, Winocour P, Farrington K. Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol. 2008;4:216-226.
31. Xiao L, Zhu X, Yang S, et al. Rap1 ameliorates renal tubular injury in diabetic nephropathy. Diabetes. 2014;63:1366-1380.
32. Sun L, Xie P, Wada J, et al. Rap1b GTPase ameliorates glucoseinduced mitochondrial dysfunction. J Am Soc Nephrol. 2008;19: 2293-2301.
33. Wang W, Wang Y, Long J, et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 2012;15:186-200.
34. Vallon V, Schroth J, Lang F, Kuhl D, Uchida S. Expression and phosphorylation of the Na-Clcotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am J Physiol Renal Physiol. 2009;297:F704-F712.
35. Rutter GA. Dorothy Hodgkin Lecture 2014. UnderstanDing genes identified by genome-wide association studies for type 2 diabetes. Diabet Med. 2014;31:1480-1487.